186 related articles for article (PubMed ID: 35968349)
1. An immune-inflamed tumor microenvironment as defined by CD8 score is associated with favorable oncologic outcomes in hepatocellular carcinoma independent of measures of tumor mutational burden.
Cherkassky L; Oshi M; Abdelfatah E; Wu R; Takabe Y; Yan L; Endo I; Takabe K
Am J Cancer Res; 2022; 12(7):3099-3110. PubMed ID: 35968349
[TBL] [Abstract][Full Text] [Related]
2. Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer.
Zaravinos A; Roufas C; Nagara M; de Lucas Moreno B; Oblovatskaya M; Efstathiades C; Dimopoulos C; Ayiomamitis GD
J Exp Clin Cancer Res; 2019 Aug; 38(1):364. PubMed ID: 31429779
[TBL] [Abstract][Full Text] [Related]
3. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
4. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
[TBL] [Abstract][Full Text] [Related]
5. CD8 T Cell Score as a Prognostic Biomarker for Triple Negative Breast Cancer.
Oshi M; Asaoka M; Tokumaru Y; Yan L; Matsuyama R; Ishikawa T; Endo I; Takabe K
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32971948
[TBL] [Abstract][Full Text] [Related]
6. Relationship Between PD-L1 Expression and CD8+ T-cell Immune Responses in Hepatocellular Carcinoma.
Huang CY; Wang Y; Luo GY; Han F; Li YQ; Zhou ZG; Xu GL
J Immunother; 2017; 40(9):323-333. PubMed ID: 29028787
[TBL] [Abstract][Full Text] [Related]
7. Association of Tumor Cell Metabolic Subtype and Immune Response With the Clinical Course of Hepatocellular Carcinoma.
Wei X; Michelakos T; He Q; Wang X; Chen Y; Kontos F; Wang H; Liu X; Liu H; Zheng W; Ferrone S; Zhang Y; Ferrone CR; Li X; Cai L
Oncologist; 2023 Nov; 28(11):e1031-e1042. PubMed ID: 37159555
[TBL] [Abstract][Full Text] [Related]
8. Expression of Programmed Cell Death-Ligands in Hepatocellular Carcinoma: Correlation With Immune Microenvironment and Survival Outcomes.
Liao H; Chen W; Dai Y; Richardson JJ; Guo J; Yuan K; Zeng Y; Xie K
Front Oncol; 2019; 9():883. PubMed ID: 31572677
[TBL] [Abstract][Full Text] [Related]
9. Monitoring Immune Checkpoint Regulators as Predictive Biomarkers in Hepatocellular Carcinoma.
Shrestha R; Prithviraj P; Anaka M; Bridle KR; Crawford DHG; Dhungel B; Steel JC; Jayachandran A
Front Oncol; 2018; 8():269. PubMed ID: 30057891
[TBL] [Abstract][Full Text] [Related]
10. VCAN, expressed highly in hepatitis B virus-induced hepatocellular carcinoma, is a potential biomarker for immune checkpoint inhibitors.
Wang MQ; Li YP; Xu M; Tian Y; Wu Y; Zhang X; Shi JJ; Dang SS; Jia XL
World J Gastrointest Oncol; 2022 Oct; 14(10):1933-1948. PubMed ID: 36310697
[TBL] [Abstract][Full Text] [Related]
11. KRAS signaling enriched triple negative breast cancer is associated with favorable tumor immune microenvironment and better survival.
Tokumaru Y; Oshi M; Katsuta E; Yan L; Satyananda V; Matsuhashi N; Futamura M; Akao Y; Yoshida K; Takabe K
Am J Cancer Res; 2020; 10(3):897-907. PubMed ID: 32266098
[TBL] [Abstract][Full Text] [Related]
12. A Prognostic Model of 15 Immune-Related Gene Pairs Associated With Tumor Mutation Burden for Hepatocellular Carcinoma.
Huo J; Wu L; Zang Y
Front Mol Biosci; 2020; 7():581354. PubMed ID: 33282911
[TBL] [Abstract][Full Text] [Related]
13. High Ki67 Gene Expression Is Associated With Aggressive Phenotype in Hepatocellular Carcinoma.
Ramos-Santillan V; Oshi M; Nelson E; Endo I; Takabe K
World J Oncol; 2024 Apr; 15(2):257-267. PubMed ID: 38545476
[TBL] [Abstract][Full Text] [Related]
14. Profiles of immune infiltration in the tumor microenvironment of hepatocellular carcinoma.
Meng L; Ma R; Yan R; Yuan D; Li Y; Shi L; Li K
J Gastrointest Oncol; 2021 Jun; 12(3):1152-1163. PubMed ID: 34295564
[TBL] [Abstract][Full Text] [Related]
15. Spinster Homologue 2 Expression Correlates With Improved Patient Survival in Hepatocellular Carcinoma Despite Association With Lymph-Angiogenesis.
Sarkar J; Oshi M; Satyananda V; Chida K; Yan L; Maiti A; Hait N; Endo I; Takabe K
World J Oncol; 2024 Apr; 15(2):181-191. PubMed ID: 38545475
[TBL] [Abstract][Full Text] [Related]
16. Activated hedgehog gene pattern correlates with dismal clinical outcome and tumor microenvironment heterogeneity in hepatocellular carcinoma.
Zhen L; Zhu Y; Wu Z; Liao J; Deng L; Ma Q; Wu Q; Ning G; Lin Q; Zhou L; Huang Y; Zhuo Z; Chen R; Yu D
Heliyon; 2024 Mar; 10(5):e26989. PubMed ID: 38468970
[TBL] [Abstract][Full Text] [Related]
17. ASF1B is a Promising Prognostic Biomarker and Correlates With Immunotherapy Efficacy in Hepatocellular Carcinoma.
Zhang S; Xu L; Feng J; Tan D; Zhu Y; Hou J; Li W; Lv K; Wang W; Jiang L; Jiao M; Guo H
Front Genet; 2022; 13():842351. PubMed ID: 35360875
[No Abstract] [Full Text] [Related]
18. Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data.
Liu S; Tang Q; Huang J; Zhan M; Zhao W; Yang X; Li Y; Qiu L; Zhang F; Lu L; He X
Aging (Albany NY); 2021 Apr; 13(8):11257-11280. PubMed ID: 33820866
[TBL] [Abstract][Full Text] [Related]
19. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma.
Dai K; Liu C; Guan G; Cai J; Wu L
BMC Cancer; 2022 May; 22(1):496. PubMed ID: 35513781
[TBL] [Abstract][Full Text] [Related]
20. Programmed Death Ligand 1 Indicates Pre-Existing Adaptive Immune Response by Tumor-Infiltrating CD8
Li YM; Yu JM; Liu ZY; Yang HJ; Tang J; Chen ZN
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31627272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
